Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Jost

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Oncogene|October 6, 2015
DNMT3A mutations mediate the epigenetic reactivation of the leukemogenic factor MEIS1 in acute myeloid leukemiaH J Ferreira, H Heyn, M Vizoso, et al.
Leukemia|November 28, 2013
Epimutations mimic genomic mutations of DNMT3A in acute myeloid leukemiaE Jost, Q Lin, C I Weidner, et al.
European Radiology|January 30, 2008
Contrast enhancement in multidetector-row computed tomography (MDCT) of the abdomen: intraindividual comparison of contrast media containing 300 mg versus 370 mg iodine per mlF F Behrendt, A H Mahnken, S Keil, et al.
Annals of Hematology|June 24, 2016
Health care setting and severity, symptom burden, and complications in patients with Philadelphia-negative myeloproliferative neoplasms (MPN): a comparison between university hospitals, community hospitals, and office-based physiciansA Kaifie, S Isfort, N Gattermann, et al.
Leukemia|October 25, 2016
Pomalidomide in myeloproliferative neoplasm-associated myelofibrosisR F Schlenk, F Stegelmann, A Reiter, et al.
Journal of Hematology & Oncology|March 6, 2016
Bleeding, thrombosis, and anticoagulation in myeloproliferative neoplasms (MPN): analysis from the German SAL-MPN-registryA Kaifie, M Kirschner, D Wolf, et al.
JACC. Basic to Translational Science|January 16, 2026
Activating PRKG1 Variant Enhances Smooth Muscle Cell Deformability To Cause AortopathyMarie E Jost, Moyra Schweizer, Philipp Henning, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Oncogene|October 6, 2015
DNMT3A mutations mediate the epigenetic reactivation of the leukemogenic factor MEIS1 in acute myeloid leukemiaH J Ferreira, H Heyn, M Vizoso, et al.
Leukemia|November 28, 2013
Epimutations mimic genomic mutations of DNMT3A in acute myeloid leukemiaE Jost, Q Lin, C I Weidner, et al.
European Radiology|January 30, 2008
Contrast enhancement in multidetector-row computed tomography (MDCT) of the abdomen: intraindividual comparison of contrast media containing 300 mg versus 370 mg iodine per mlF F Behrendt, A H Mahnken, S Keil, et al.
Annals of Hematology|June 24, 2016
Health care setting and severity, symptom burden, and complications in patients with Philadelphia-negative myeloproliferative neoplasms (MPN): a comparison between university hospitals, community hospitals, and office-based physiciansA Kaifie, S Isfort, N Gattermann, et al.
Leukemia|October 25, 2016
Pomalidomide in myeloproliferative neoplasm-associated myelofibrosisR F Schlenk, F Stegelmann, A Reiter, et al.
Journal of Hematology & Oncology|March 6, 2016
Bleeding, thrombosis, and anticoagulation in myeloproliferative neoplasms (MPN): analysis from the German SAL-MPN-registryA Kaifie, M Kirschner, D Wolf, et al.
JACC. Basic to Translational Science|January 16, 2026
Activating PRKG1 Variant Enhances Smooth Muscle Cell Deformability To Cause AortopathyMarie E Jost, Moyra Schweizer, Philipp Henning, et al.
Pageof 6